Tag:
transdermal drug delivery
Latest Headlines
Latest Headlines
Japanese firm buys Altea's assets, plans to launch transdermal tech
Nitto Denko has acquired all of Altea's assets, planning to use the company's transdermal technology to launch a patch on its own.
Echo's trandsdermal tech gets positive results, TV time
Echo Therapeutics is reporting positive clinical trial results for its transdermal glucose monitor, and its CEO will get a chance to discuss them on national TV.
Swedish discovery could be key to better transdermal delivery
Scientists at Karolinska Institutet believe their breakthrough in understanding the skin's outermost layer could revolutionize transdermal delivery.
Phosphagenics brings transdermal tech to India with Intas deal
Australia's Phosphagenics is looking to tap the Indian market, inking a deal with Intas Pharmaceuticals to push its transdermal platform there.
Echo Therapeutics reports $16.7M loss after Prelude delay
Philadelphia-based Echo Therapeutics took a $16.7 million loss in 2011, a year in which the company had planned to launch its needle-free, transdermal drug delivery platform, the Prelude SkinPrep System.
Echo Therapeutics video shows pain-free skin prep
When last we left Echo Therapeutics in February , the Franklin, MA-based company was speeding up the launch of its Prelude SkinPrep System for transdermal drug delivery after receiving word from the
Battery-powered patch delivers drugs for peripheral artery disease
Scientists say that problems with injected treatments for peripheral artery disease (PAD) could be solved by a skin patch hooked up to a battery. Caused by blocked arteries in the leg, PAD can be
Echo Therapeutics: Prelude delivery device launch on track
Franklin, MA-based Echo Therapeutics is speeding up the launch of its non-invasive drug delivery system and announced plans to list on a national exchange. The company, along with its partners
HepaLife launches subsidiary for transdermal drug delivery
HepaLife Technologies, based in New York, is launching a new subsidiary that will take advantage of the transdermal drug delivery technology it acquired when it bought AquaMed Technologies in May.
TransPharma has successful diabetes trial
TransPharma Medical, a Lod, Israel-based company developing transdermal drug delivery technology, has completed a Phase Ia trial of its ViaDerm-GLP1 agonist being developed to treat Type 2 diabetes.
